What changed after the 2022 guidelines for pulmonary hypertension?

Mona Lichtblau; Anna Titz; Barbara Bahrampoori; Mark Schmiedeskamp; Silvia Ulrich

doi:10.1016/j.ejim.2023.08.021

What changed after the 2022 guidelines for pulmonary hypertension?

Eur J Intern Med. 2023 Dec:118:1-5. doi: 10.1016/j.ejim.2023.08.021. Epub 2023 Sep 4.

Authors

Mona Lichtblau¹, Anna Titz², Barbara Bahrampoori², Mark Schmiedeskamp², Silvia Ulrich³

Affiliations

¹ Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland. Electronic address: mona.lichtblau@usz.ch.
² Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
³ Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.

PMID: 37673774
DOI: 10.1016/j.ejim.2023.08.021

Abstract

With an estimated prevalence of around 1%, pulmonary hypertension (PH) presents a relevant burden worldwide. In this review, we aim to give an overview of the novelties from the revised European Society of Cardiology (ESC) /European Respiratory Society (ERS) guidelines for the diagnosis and treatment of PH and their implication for the everyday clinical practice.

Keywords: Pulmonary hypertension; Risk assessment; Screening; Treatment.

Publication types

Review

MeSH terms

Cardiology*
Humans
Hypertension*
Hypertension, Pulmonary* / diagnosis
Hypertension, Pulmonary* / therapy